MattAaronCavenderMDMPH
Cardiology • Chapel Hill, NCInterventional Cardiology, Peripheral Endovascular Interventional Cardiology
Physician
Dr. Cavender is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Office
300 Meadowmont Village Cir
Chapel Hill, NC 27517Phone+1 984-974-2900Fax+1 984-974-2985
Education & Training
Brigham and Womens HospitalFellowship, Structural and Peripheral Cardiology, 2015 - 2016- Brigham and Women's HospitalFellowship, Interventional Cardiology, 2014 - 2015
- Brigham and Women's HospitalPost-Doctoral Fellowship, 2012 - 2014
Cleveland Clinic FoundationFellowship, Cardiovascular Disease, 2009 - 2012
Duke University HospitalResidency, Internal Medicine, 2006 - 2009
University of Alabama School of MedicineClass of 2006
Certifications & Licensure
NH State Medical License 2015 - Present
NC State Medical License 2006 - 2025
MA State Medical License 2012 - 2021
AL State Medical License 2014 - 2014
OH State Medical License 2009 - 2013- American Board of Internal Medicine Cardiovascular Disease
- American Board of Internal Medicine Interventional Cardiology
Clinical Trials
- Promoting Shared Decision Making for Severe Aortic Stenosis Start of enrollment: 2024 Mar 01
Roles: Contact
Publications & Presentations
PubMed
- 31 citationsConsistent Reduction in Periprocedural Myocardial Infarction With Cangrelor as Assessed by Multiple Definitions: Findings From CHAMPION PHOENIX (Cangrelor Versus Stand...Matthew A. Cavender, Deepak L. Bhatt, Gregg W. Stone, Harvey D. White, Ph. Gabriel Steg
Circulation. 2016-09-06 - 33 citationsPrevalence and Prognostic Significance of Mitral Regurgitation in Acute Decompensated Heart Failure: The ARIC Study.Sameer Arora, Krishan Sivaraj, Michael Hendrickson, Patricia P. Chang, Thelsa Weickert
JACC. Heart Failure. 2021-03-01 - 60 citationsHeart Failure, Saxagliptin, and Diabetes Mellitus: Observations from the SAVOR-TIMI 53 Randomized Trial.B M Scirica, E Braunwald, I Raz, M A Cavender, D A Morrow
Circulation. 2015-10-13
Press Mentions
Novel Therapies: Using GLP-1 Receptor Agonists in Cardiorenal Metabolic SyndromeAugust 20th, 2024
Special Issue of JACC Examines Public Health Impact of CVD and Its PreventionMay 28th, 2018
Professional Memberships
- Member
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence:
